Pluristem Therapeutics
Pluristem Therapeutics is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment.
Org chart
Discover similar companies
Evogene
Post IPO Equity • Rehovot, Israel
Compugen
Post IPO Equity • Holon, Israel
IsoPlexis
Post IPO Equity • Branford, United States
Evofem Biosciences
Post IPO Equity • San Diego, United States
Summit Therapeutics
Post IPO Equity • Cambridge, United States
Protagonist Therapeutics
Post IPO Equity • Newark, United States
OncoSec
Post IPO Equity • San Diego, United States
Otonomy
Post IPO Equity • San Diego, United States
Sutro Biopharma
Post IPO Equity • South San Francisco, United States
Abeona Therapeutics
Post IPO Equity • Dallas, United States
Sorrento Therapeutics
Post IPO Equity • San Diego, United States
Cara Therapeutics
Post IPO Equity • Stamford, United States
helps you hire
great candidates
It’s free to use - try it out today.